Clinical trials
Recruiting Phase 3 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| InnoPharmax Inc. | 1 |
| J-Pharma Co., Ltd. | 1 |
| Jazz Pharmaceuticals | 1 |
| Taiho Pharmaceutical Co., Ltd. | 1 |
| Tata Memorial Centre | 1 |
| UNICANCER | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 10 |
| Cholangiocarcinoma | 3 |
| Gallbladder Neoplasms | 3 |
| Acrocephalosyndactylia | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.